Administration of PLGA nanoparticles carrying shRNA against focal adhesion kinase and CD44 results in enhanced antitumor effects against ovarian cancer

15:01 EDT 15 Mar 2013 | Nature Publishing

Original Article: Administration of PLGA nanoparticles carrying shRNA against focal adhesion kinase and CD44 results in enhanced antitumor effects against ovarian cancer

NEXT ARTICLE

More From BioPortfolio on "Administration of PLGA nanoparticles carrying shRNA against focal adhesion kinase and CD44 results in enhanced antitumor effects against ovarian cancer"

Search BioPortfolio:
Loading
Advertisement
Advertisement

Searches Linking to this Story